Shawn McCormick

CIK: 0001454092

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)1 (11.1%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)1 (11.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INSP

Inspire Medical Systems, Inc.

Director

NVRO

NEVRO CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

INSP
Inspire Medical Systems, Inc.
May 8, 2026
Sale(S)
Direct
696 shares at avg. $45.31$32K
INSP
Inspire Medical Systems, Inc.
Apr 30, 2026
Award(A)
Direct
3.6K shares-
INSP
Inspire Medical Systems, Inc.
Dec 2, 2025
Sale(S)
Direct
1.2K shares at avg. $139.00$167K
INSP
Inspire Medical Systems, Inc.
Nov 28, 2025
Sale(S)
Direct
2K shares at avg. $127.48$255K
INSP
Inspire Medical Systems, Inc.
Jun 4, 2025
Exercise(M)
Direct
4K shares at avg. $16.00$64K
INSP
Inspire Medical Systems, Inc.
May 2, 2025
Sale(S)
Direct
360 shares at avg. $160.00$58K
INSP
Inspire Medical Systems, Inc.
May 1, 2025
Award(A)
Direct
1.3K shares-
NVRO
NEVRO CORP
Apr 3, 2025
Disposition(D)
Direct
46K shares-
INSP
Inspire Medical Systems, Inc.
Sep 9, 2024
Sale(S)
Direct
800 shares at avg. $220.00$176K

		Type	Shares	Price		Ownership
May 8, 2026	INSP Inspire Medical Systems, Inc.	Sale(S)	696	$45.31	$31,536	Direct
Apr 30, 2026	INSP Inspire Medical Systems, Inc.	Award(A)	3,562	-	$0	Direct
Dec 2, 2025	INSP Inspire Medical Systems, Inc.	Sale(S)	1,200	$139.00	$166,800	Direct
Nov 28, 2025	INSP Inspire Medical Systems, Inc.	Sale(S)	2,000	$127.48	$254,960	Direct
Jun 4, 2025	INSP Inspire Medical Systems, Inc.	Exercise(M)	4,000	$16.00	$64,000	Direct
May 2, 2025	INSP Inspire Medical Systems, Inc.	Sale(S)	360	$160.00	$57,600	Direct
May 1, 2025	INSP Inspire Medical Systems, Inc.	Award(A)	1,266	-	-	Direct
Apr 3, 2025	NVRO NEVRO CORP	Disposition(D)	46,035	-	-	Direct
Sep 9, 2024	INSP Inspire Medical Systems, Inc.	Sale(S)	800	$220.00	$176,000	Direct

1-9 of 9 transactions

About McCormick Shawn

McCormick Shawn (SEC CIK 0001454092) files insider reports with the SEC as Director of Inspire Medical Systems, Inc. (INSP) and Director of NEVRO CORP (NVRO).

Signal8 holds 8 ownership filings by McCormick Shawn, all Form 4s, filed between Sep 11, 2024 and May 11, 2026. Those filings report 9 transactions, from Sep 9, 2024 to May 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McCormick Shawn's filings is in GOLDEN VALLEY, MN.

Recent filings by McCormick Shawn

May 8, 2026: Open-market sale of INSP shares (Form 4, code S).
Apr 30, 2026: Grant or award of INSP shares (Form 4, code A).
Dec 2, 2025: Open-market sale of INSP shares (Form 4, code S).
Nov 28, 2025: Open-market sale of INSP shares (Form 4, code S).
Jun 4, 2025: Option exercise of INSP shares (Form 4, code M).

Other insiders filing for Inspire Medical Systems, Inc. (INSP)

Ellis Gary Lee, Director
Melenikiotou Georgia, Director
CARREL MICHAEL H, Director
Broader Shelley G, Director
Kelly Jason P
Mann Melissa, Chief People Officer

How to read Form 4 transaction codes